Presenter: Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD
In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed…
BS Medicine Episode #624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?
FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale
FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care
Presenter(s):
Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD








Please provide any additional comments (optional).